Skip to content

Granulocyte apoptosis: death by a secreted lipocalin?

December 11, 2009
S Yousefi and H U Simon

Department of Pharmacology, University of Bern, Friedbühlstrasse 49, CH-3010 Bern, Switzerland

Correspondence to: S Yousefi, Tel: 41 31 632 3281; Fax: 41 31 632 4992; E-mail:


Cell Death and Differentiation (2002) 9, 595-597. DOI: 10.1038/sj/cdd/4401037

Granulocytes are terminally differentiated cells generated in the bone marrow under the influence of various cytokines. They are important components of the natural defense system. Under normal circumstances, granulocytes have a very short life span that does not exceed more than 2-3 days. One mechanism to accumulate granulocytes at sites of inflammation is delayed apoptosis, which is at least partially mediated by overexpression of cytokines.1 In many chronic inflammatory responses, such as lung fibrosis or bronchial asthma, granulocytes (neutrophils and/or eosinophils) cause unwanted tissue damage via the release of toxic mediators. Clearly, induction of granulocyte apoptosis would help to limit tissue damage and to reduce inflammation in these cases. Therefore, investigating the molecular control of granulocyte apoptosis under normal and inflammatory conditions may lead to the identification of new therapeutic drug targets.

What is the mechanism ultimately responsible for the induction of apoptosis in granulocytes? Several laboratories tried to approach this question by comparing the expression and function of apoptosis-regulating proteins in granulocytes under conditions of cytokine withdrawal and survival factor exposure. These studies revealed that both neutrophils2 and eosinophils3 decrease the functional activity of proapoptotic Bax in the presence of survival factors, suggesting that this member of the Bcl-2 family plays a key role in granulocyte apoptosis. Moreover, cytokine withdrawal induced expression of Bax in neutrophils (Figure 1A).2 Since overexpression of Bax has been shown to induce apoptosis,4 it is possible that a single granulocyte activates its intracellular death machinery as soon as a certain threshold concentration of Bax is reached.

Besides Bax, another pro-apoptotic member of the Bcl-2 family, Bim, has recently been implicated in apoptosis mediated by growth factor withdrawal in a mouse IL-3 dependent cell line as well as in primary mouse fetal liver cells.5 Whether Bim plays a role in the induction of spontaneous apoptosis of granulocytes remains to be investigated. Granulocytes may increase Bim levels in the absence of survival factors leading to the neutralization of pro-survival members of the Bcl-2 family (Figure 1A).5 Interestingly, both Bim5 and Fas ligand6 are under the control of forkhead transcription factor FKHR-L1. However, there is only little evidence to suggest that Fas ligand is upregulated in granulocytes cultured in the absence of survival factors in vitro.7

The presence of Fas ligand and Fas receptors on the surface of granulocytes still implied the possibility that granulocytes initiate a death pathway at the cell surface.8 This idea was supported by observations made in T cells. Activated T cells express high levels of functional Fas ligand and Fas receptor (CD95) leading to the induction of apoptosis in an autocrine or paracrine manner,9 at least in the absence of T cell survival factors.10 Therefore, molecular Fas ligand/Fas receptor interactions have also been implicated as initial events responsible for the so-called 'spontaneous' apoptosis in these cells.8,11 However, recent work suggests that this hypothesis must be rejected in the granulocyte system.12,13,14 Nevertheless, although Fas receptor activation does not appear to be required for spontaneous apoptosis, it is associated with additional induction of neutrophil15 and eosinophil16 apoptosis both in the presence and absence of survival cytokines in vitro. The nature of Fas ligand/Fas receptor molecular interactions affecting granulocyte apoptosis in vivo remains to be determined.

A new potential mechanism responsible for the initiation of apoptosis in granulocytes has recently been suggested by LR Devireddy et al.17 By using DNA microarrays, they searched for death-promoting genes that are transcriptionally activated in IL-3-deprived mouse pro-B lymphocytic FL5.12 cells. Eight hours following IL-3 withdrawal, they observed a 12.6-fold increase in 24p3, a gene which belongs the lipocalin family.18 By using Northern blot analysis, 24p3 gene expression was detected within 2 h following IL-3 withdrawal in FL5.12 cells, mouse 32D cells and mouse primary bone marrow cells.17 Interestingly, conditioned medium of IL-3-deprived FL5.12 and bone marrow cells induced apoptosis in a variety of primary cells including neutrophils (Figure 1A). That 24p3 protein is able to induce apoptosis in target cells was demonstrated by several means: (1) Overexpression of 24p3 induced apoptosis in COS-7 monkey kidney and FL5.12 cells. (2) Recombinant 24p3 induced apoptosis in FL5.12 and bone marrow cells. (3) 24p3 phosphorothioate antisense oligonucleotides prevented death of FL5.12 cells after IL-3 withdrawal. (4) Neutralization of 24p3 protein using an anti-24p53 antibody blocked apoptosis of IL-3-deprived bone marrow cells. Taken together, these data suggested that 24p3 protein is a death factor, which is generated by cytokine-dependent cells following growth factor withdrawal.

The identification of a released cellular product that can induce apoptosis in susceptible cells including neutrophils implies that this mechanism may also play an important role in spontaneous granulocyte apoptosis. Immature neutrophils have been shown to generate Neutrophil Gelatinase-Associated Lipocalin (NGAL),19 the likely human homolog of 24p53 (Figure 1B). Expression studies in mature neutrophils following in vitro culture in the presence and absence of survival factors have not been reported so far. Nevertheless, NGAL is a new candidate, which might largely be involved in the induction of apoptosis via an unknown cell surface receptor in mature granulocytes (Figure 1A). Clearly, the identification of this receptor is a prerequisite for the identification of the death pathway initiated by NGAL.

The fact that 24p53 also induced apoptosis in lymphocytes17 suggests that this lipocalin might be involved in the homeostasis of leukocytes in general. Perhaps, 24p53/NGAL-mediated apoptosis plays an equally important role as Fas ligand/Fas receptor molecular interactions in the regulation of the immune system. For example, similar to the Fas system, overexpression of 24p53/NGAL has been reported on immunoprivileged sites,20 supporting its potential role in limiting inflammatory responses.

Although the current data on 24p53 are interesting, much more work has to be performed to clarify its role in granulocyte apoptosis. So far we just know that mouse 24p53 induced apoptosis in human blood neutrophils. The following immediate questions need to be answered: (1) Is it possible to delay granulocyte apoptosis by adding neutralizing anti-24p53/NGAL antibody or phosphorothioate antisense oligonucleotides in vitro? (2) Is 24p53/NGAL expressed in granulocytes and how is the kinetic during culture in the presence and absence of survival factors? (3) What is the receptor of 24p53/NGAL and how is it linked to caspase activation? When we have answered these questions, we will be better able to estimate the potential role of 24p53/NGAL as an initiator of spontaneous granulocyte apoptosis.


The laboratory of the authors is supported by the Swiss National Science Foundation (grant no. 31-58916.99) and the Helmut Horten Foundation (Madonna del Piano).


1 Simon HU. (2001). Immunol. Rev., 179: 156-162. Article MEDLINE

2 Dibbert B et al. (1999). PNAS, 96: 13330-13335. MEDLINE

3 Dewson G et al. (2001). Blood, 98: 2239-2247. MEDLINE

4 Xiang J et al. (1996). PNAS, 93: 14559-14563. MEDLINE

5 Dijkers PF et al. (2000). Current Biology, 10: 1201-1204. Article MEDLINE

6 Brunet A et al. (1999). Cell, 96: 857-868. MEDLINE

7 Daigle I, Simon HU. (2001). Int. Arch. Allergy Immunol: 126: 147-156.

8 Liles WC. (1996). J. Exp. Med., 184: 429-440. MEDLINE

9 Dhein J et al. (1995). Nature, 373: 438-441. MEDLINE

10 Akbar AN, Salmon M. (1997). Immunol. Today. 18: 72-76.

11 Liles WC, Klebanoff SJ. (1995). J. Immunol., 155: 3289-3291. MEDLINE

12 Fecho K, Cohen PL. (1998). J. Leukoc. Biol., 64: 373-383. MEDLINE

13 Brown SB, Savill J. (1999). J. Immunol., 162: 480-485. MEDLINE

14 Villunger A et al. 2000. J. Exp. Med., 192: 647-657.

15 Daigle I et al. (2002). Nat. Med., 8: 61-67. Article MEDLINE

16 Hebestreit H et al. (1996). Eur. J. Immunol., 26: 1775-1780. MEDLINE

17 Devireddy LR et al. (2001). Science, 293: 829-833. MEDLINE

18 Flower DR. (1996). Biochem. J., 318: 1-14. MEDLINE

19 Bundgaard JR et al. 1994. Biochem. Biophys. Res. Commun., 202: 1468-1475.

20 Liu Q et al. 1997. Mol. Reprod. Dev., 46: 507-514.

Posted via email from healthystealthy health hacks

No comments yet

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: